COVID-19 Treatments: No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxych loroquine and azithromycin in patients with severe COVID-19 infection

3/28

Negative

Late treatment study

Molina et al., Médecine et Maladies Infectieuses, 50:4, June 2020, 10.1016/j.medmal.2020.03.006 (preprint 3/28) (Letter)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxych loroquine and azithromycin in patients with severe COVID-19 infection

11 patients with severe cases. No evidence of benefit for HC Q. Binary PCR evaluation with an unknown Ct.

Source

See all 155 studies

Please send us corrections, updates, or comments.

Submit